These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21829202)

  • 1. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
    Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
    Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
    Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
    Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Including a general practice endorsement letter with the testing kit in the Bowel Cancer Screening Programme: Results of a cluster randomised trial.
    Cross AJ; Myles J; Greliak P; Hackshaw A; Halloran S; Benton SC; Addison C; Chapman C; Djedovic N; Smith S; Wagner CV; Duffy SW; Raine R
    J Med Screen; 2021 Dec; 28(4):419-425. PubMed ID: 33645308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner.
    Cole SR; Young GP; Byrne D; Guy JR; Morcom J
    J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
    Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
    BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
    Benton SC; Butler P; Allen K; Chesters M; Rickard S; Stanley S; Roope R; Vulkan D; Duffy SW
    Br J Cancer; 2017 Jun; 116(12):1551-1557. PubMed ID: 28524157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
    Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
    Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.
    Hart AR; Barone TL; Gay SP; Inglis A; Griffin L; Tallon CA; Mayberry JF
    J Epidemiol Community Health; 1997 Apr; 51(2):187-91. PubMed ID: 9196650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using primary care-based paper and telephone interventions to increase uptake of bowel scope screening in Yorkshire: a protocol of a randomised controlled trial.
    McGregor LM; Kerrison RS; Green T; Macleod U; Hughes M; Gibbins M; Morris S; Rees C; von Wagner C
    BMJ Open; 2018 Jul; 8(7):e024616. PubMed ID: 30056395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying behavioural science to increase uptake of the NHS Health Check: a randomised controlled trial of gain- and loss-framed messaging in the national patient information leaflet.
    Gold N; Durlik C; Sanders JG; Thompson K; Chadborn T
    BMC Public Health; 2019 Nov; 19(1):1519. PubMed ID: 31727030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial.
    Aubin-Auger I; Laouénan C; Le Bel J; Mercier A; Baruch D; Lebeau JP; Youssefian A; Le Trung T; Peremans L; Van Royen P
    Eur J Cancer Care (Engl); 2016 Jan; 25(1):18-26. PubMed ID: 25851842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
    Senore C; Ederle A; DePretis G; Magnani C; Canuti D; Deandrea S; Zorzi M; Barca A; Bestagini P; Faitini K; Bisanti L; Casale C; Ferro A; GiorgiRossi P; Quadrino F; Fiorina G; Capuano A; Segnan N; Fantin A
    Prev Med; 2015 Apr; 73():106-11. PubMed ID: 25602908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
    von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
    BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a GP-endorsed non-participant reminder letter to promote uptake of bowel scope screening: A randomised controlled trial in a hard-to-reach population.
    Kaushal A; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Duffy S; von Wagner C
    Prev Med; 2020 Dec; 141():106268. PubMed ID: 33022321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.